GlassScriptPhysician profile
Tanner J Vick
NPI 1487632667
$812.64
in general payments reported to CMS, 2019-2025
10 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $231 · 2022: $63.98 · 2023: $163 · 2024: $29.80 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $273.03 | 2021-2023 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore-Tex Vascular Graft |
| Shockwave Medical, INC | $207.95 | 2025 | |
| Abbvie INC. | $117.25 | 2025 | |
| Medtronic, INC. | $97.53 | 2022-2024 | Venaseal, Heli-Fx Endoanchor System |
| Terumo Medical Corporation | $30.45 | 2022 | |
| Biotronik INC. | $19.01 | 2023 | Pulsar-18 T3 |
| Integra Lifesciences Corporation | $18.10 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bard Peripheral Vascular, INC. | $17.76 | 2022 | |
| Endologix LLC | $16.60 | 2021 | |
| Boston Scientific Corporation | $14.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanner Vick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.